title: Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis.
authors.forename: Zaher K
authors.initials: ZK
authors.lastname: Otrock
authors.forename: Rami A
authors.initials: RA
authors.lastname: Mahfouz
authors.forename: Khalil M
authors.initials: KM
authors.lastname: Charafeddine
authors.forename: Roni F
authors.initials: RF
authors.lastname: Rayes
authors.forename: Laila F
authors.initials: LF
authors.lastname: Zahed
authors.forename: Ali T
authors.initials: AT
authors.lastname: Taher
mesh_terms: D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D004164:Diphosphonates / Q000627:therapeutic use*; D005838:Genotype; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D018167:Receptors, Calcitriol / Q000235:genetics*; D013789:Thalassemia / Q000150:complications; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D018167:Receptors, Calcitriol; D000077211:Zoledronic Acid